Maternal immune correlates of protection against placental transmission of cytomegalovirus

7Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Human cytomegalovirus (HCMV) is the most common congenitally transmitted pathogen worldwide, impacting an estimated 1 million newborns annually. In a subset of infected infants, congenital HCMV causes severe, long-lasting sequelae, including deafness, microcephaly, neurodevelopmental delay, and even death. Accordingly, a maternal vaccine to prevent congenital HCMV infection continues to be a top public health priority. Nevertheless, all vaccines tested to date have failed to meet clinical trial endpoints. Maternal immunity provides partial protection against congenital HCMV transmission, as vertical transmission from seropositive mothers is relatively rare. Therefore, an understanding of the maternal immune correlates of protection against HCMV congenital infection will be critical to inform design of an efficacious maternal vaccine. This review summarizes our understanding of the innate and adaptive immune correlates of protection against congenital transmission of HCMV, and discusses the advantages and applications of a novel nonhuman primate model of congenital CMV transmission to aid in rational vaccine design and evaluation.

Cite

CITATION STYLE

APA

Itell, H. L., Nelson, C. S., Martinez, D. R., & Permar, S. R. (2017). Maternal immune correlates of protection against placental transmission of cytomegalovirus. Placenta, 60, S73–S79. https://doi.org/10.1016/j.placenta.2017.04.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free